Maternal IgG Anti-A and Anti-B Titer Levels Screening in Predicting ABO Hemolytic Disease of the Newborn: A Meta-Analysis

REFERENCES

• Gessoni G, Valverde S, Giacomini A, et al. Foetal-maternal alloimmunizations in the South-East area of the Venice province. Minerva Ginecol 2002;54:333–338.
   PubMedGoogle Scholar
• Bhat YR, Kumar CG. Morbidity of ABO haemolytic disease in the newborn. Paediatr Int Child Health 2012;32:93–96.
   PubMed Web of Science ®Google Scholar
• Murray NA, Roberts IA. Haemolytic disease of the newborn. Arch Dis Child Fetal Neonatal Ed 2007;92:F83–88.
   PubMed Web of Science ®Google Scholar
• Wan MR. Serum ABO immune antibodies in 1944 pregnant women. Zhonghua Fu Chan Ke Za Zhi 1991;26:12–1.
   PubMedGoogle Scholar
• Wu Q, Zhang Y, Liu M, et al. Correlation of Fc(gamma)RIIa (CD32) Polymorphism and IgG antibody subclasses in hemolytic disease of newborn. Neonatology 2009;96:1–5.
   PubMed Web of Science ®Google Scholar
• Bennardello F, Curciarello G. Survey on the prevention and incidence of haemolytic disease of the newborn in Italy. Blood Transfus 2013;11:518–527.
   PubMed Web of Science ®Google Scholar
• Wang M, Hays T, Ambruso DR, et al. Hemolytic disease of the newborn caused by a high titer anti-group B IgG from a group A mother. Pediatr Blood Cancer 2005;45:861–862.
   PubMed Web of Science ®Google Scholar
• Ziprin JH, Payne E, Hamidi L, et al. ABO incompatibility due to immunoglobulin G anti-B antibodies presenting with severe fetal anaemia. Transfus Med 2005;15:57–60.
   PubMed Web of Science ®Google Scholar
• Curtis BR, Fick A, Lochowicz AJ, et al. Neonatal alloimmune thrombocytopenia associated with maternal-fetal incompatibility for blood group B. Transfusion 2008;48:358–364.
   PubMed Web of Science ®Google Scholar
• Kato S, Sugiura T, Ueda H, et al. Massive intracranial hemorrhage caused by neonatal alloimmune thrombocytopenia associated with anti-group Aantibody. J Perinatol 2013;33:79–82.
   PubMed Web of Science ®Google Scholar
• Weng YH1, Chiu YW. Spectrum and outcome analysis of marked neonatal hyperbilirubinemia with blood group incompatibility. Chang Gung Med J 2009;32:400–408.
   PubMedGoogle Scholar
• Kalakheti BK, Singh R, Bhatta NK, Karki A, Baral N. Risk of neonatal hyperbilirubinemia in babies born to ‘O’ positive mothers: A prospective cohort study. Kathmandu Univ Med J (KUMJ) 2009;7:11–15.
   PubMedGoogle Scholar
• Hassanzadeh-Nazarabadi M, Shekouhi S, Seif N. The incidence of spontaneous abortion in mothers with blood group O compared with other blood types. Int J Mol Cell Med 2012;1:99–104.
   PubMedGoogle Scholar
• Chen JY, Ling UP. Prediction of the development of neonatal hyperbilirubinemia in ABO incompatibility. Zhonghua Yi Xue Za Zhi (Taipei) 1994;53:13–18.
   PubMedGoogle Scholar
• Owa JA, Durosinmi MA, Alabi AO. Determinants of severity of neonatal hyperbilirubinaemia in ABO incompatibility in Nigeria. Trop Doct 1991;21:19–22.
   PubMed Web of Science ®Google Scholar
• Egil B, Unni B, Unni B, et al. Maternal IgG anti-A and anti-B titres predict outcome in ABO-incompatibility in the neonate. Acta Paediatr 2009;98:1896–1901.
   PubMed Web of Science ®Google Scholar
• Wong KF, Tse KT, Lee AW, et al. Is antenatal antibody screening worthwhile in Chinese? Br J Haematol 1997;97:917–919.
   PubMed Web of Science ®Google Scholar
• Kaplan M, Na'amad M, Kenan A, et al. Failure to predict hemolysis and hyperbilirubinemia by IgG subclass in blood group A or B infants born to group O mothers. Pediatrics 2009;123:e132–137.
   PubMed Web of Science ®Google Scholar
• Cariani L, Romano EL, Martinez N, et al. ABO-haemolytic disease of the newborn (ABO-HDN): Factors influencing its severity and incidence in Venezuela. J Trop Pediatr 1995;41:14–21.
   PubMed Web of Science ®Google Scholar
• Van Dijk BA, Dooren MC, Overbeeke MA. Red cell antibodies in pregnancy: there is no ‘critical titre’. Transfus Med 1995;5:199–202.
   PubMed Web of Science ®Google Scholar
• Brouwers HA, Overbeeke MA, van Ertbruggen I, et al. What is the best predictor of the severity of ABO-haemolytic disease of the newborn? Lancet 1988;2:641–644.
   PubMed Web of Science ®Google Scholar
• Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996;17:1–12.
   PubMedGoogle Scholar
• Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002;21:1539–1558.
   PubMed Web of Science ®Google Scholar
• Zintzaras E, Ioannidis JP. Heterogeneity testing in meta-analysis of genome searches. Genet Epidemiol 2005;28:123–137.
   PubMed Web of Science ®Google Scholar
• Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple graphical test. BMJ 1997;315:629–634.
   PubMed Web of Science ®Google Scholar
• Lynen R, Krone O, Legler TJ. A newly developed gel centrifugation test for quantification of RBC-bound IgG antibodies and their subclasses IgG1 and IgG3:comparison with flow cytometry. Transfusion 2002;42:612–618.
   PubMed Web of Science ®Google Scholar
• Egil B, Unni B, Unni B, et al. Maternal IgG anti-A and anti-B titres predict outcome in ABO-incompatibility in the neonate. Acta Paediatr 2009;98:1896–1901.
   PubMed Web of Science ®Google Scholar
• Yang SM, Wu QY, Luo HQ, et al. Correlation of newborn hemolytic disease with ABO antibodies in sera of pregnant women. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2005;13:875–877.
   PubMedGoogle Scholar
• Zhu Y-h, Wu W-j, Ma C-h, et al. Relationship between blood group antibody IgG titer of pregnant women and ABO hemolytic disease of newborn in ten provinces and cities in China. Chinese J Biol 2012;25:477–479.
   Google Scholar
• Akgül S, Korkmaz A, Yiğit S, Yurdakök M. Neonatal hyperbilirubinemia due to ABO incompatibility: does blood group matter? Turk J Pediatr 2013;55:506–509.
   PubMed Web of Science ®Google Scholar
• Sarıcı SU. ABO incompatibility: which one matters? Turk J Pediatr 2014;56:216.
   PubMed Web of Science ®Google Scholar
• Mathai J, Sindhu PN, Sulochana PV, et al. Haemolysin test for characterization of immune ABO antibodies. Indian J Med Res 2003;118:125–128.
   PubMed Web of Science ®Google Scholar